Health
Vaccine by Christmas amid record cases in the US – News Mail
The Oxford vaccine trial has produced a positive response, as more than half US states reported their highest day of new cases.
A vaccine candidate for COVID-19 developed by the University of Oxford with the backing of pharmaceutical giant AstraZeneca has produced positive results.
The test jabs have triggered robust immune responses in adults.
According to Bloomberg, findings from blood tests which were carried out on a group of older trial participants reinforce data released in July which suggest the vaccine is effective for adults aged between 18 and 55, Astra announced on Monday local time.
Results from the study show…
-
Noosa News20 hours agoBar Monte, Newstead Review
-
Business21 hours agoWhy is everyone talking about Droneshield shares this week?
-
Noosa News19 hours agoMagpies overlook Bobby Hill for AFL preliminary final against Lions
-
Noosa News21 hours agoAustralian cow market at record high as US demand hits ‘scary times’